
B. Riley Securities upgrades Madrigal Pharmaceuticals Inc (MDGL) rating to a Buy
Madrigal Pharmaceuticals Inc’s filing revealed that its Director Taub Rebecca unloaded Company’s shares for reported $0.35 million on Jul 18
Madrigal Pharmaceuticals Inc’s filing revealed that its Director Taub Rebecca unloaded Company’s shares for reported $0.35 million on Jul 18
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Madrigal Pharmaceuticals Inc’s filing revealed that its Director Taub Rebecca unloaded Company’s shares for reported $0.35 million on Jul 18
Madrigal Pharmaceuticals Inc’s filing revealed that its Director Taub Rebecca unloaded Company’s shares for reported $0.35 million on Jul 18
Madrigal Pharmaceuticals Inc’s filing revealed that its Director CRAVES FRED B unloaded Company’s shares for reported $2.56 million on Mar
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Madrigal Pharmaceuticals
Madrigal Pharmaceuticals Inc’s recent filing unveils that its Director CRAVES FRED B unloaded Company’s shares for reported $2.56 million on
Madrigal Pharmaceuticals Inc’s filing revealed that its Director CRAVES FRED B unloaded Company’s shares for reported $2.56 million on Mar
Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) does about 630.57K shares in volume on a normal day but saw 614901 shares change hands